首页 | 本学科首页   官方微博 | 高级检索  
检索        

口腔鳞癌中CD24的表达、作用和治疗靶点价值
引用本文:莫珩,高承志,王少杰,李玫,董建强,郁卫东.口腔鳞癌中CD24的表达、作用和治疗靶点价值[J].北京大学学报(医学版),2016,48(1):16-22.
作者姓名:莫珩  高承志  王少杰  李玫  董建强  郁卫东
作者单位:(北京大学人民医院1.口腔科, 2.中医科, 3.临床分子生物学研究所, 北京100044)
基金项目:国家自然科学基金(30872923)资助Supported by the National Natural Science Foundation of China (30872923)
摘    要:目的:明确口腔鳞癌组织和细胞中黏液素样细胞表面黏附分子CD24的表达模式、作用及其作为治疗靶点的潜在价值。方法:利用免疫组化、real-time RT-PCR和Western blot方法,明确CD24在78例人口腔组织标本和59例动物模型金地鼠(Hamster buccal)颊囊组织标本,以及口腔癌前病变上皮细胞DOK4、口腔鳞癌细胞CAL-27和WSU-HN6中的表达模式;以CAL-27和WSU-HN6细胞为模型,明确在常规和无血清成球培养条件下,全反式维甲酸(all-trans retinoic acid, ATRA)和CD24抗体对CAL-27和WSU-HN6细胞及肿瘤球生长的影响,并观察它们是否影响这两种细胞中CD24的表达。结果:人和金地鼠组织的免疫组织染色结果显示,在正常/单纯增生组织、轻度/中度异常增生组织、重度异常增生和鳞癌组织中均依次呈现CD24表达递增的现象(P<0.05);与DOK细胞相比较,CAL-27和WSU-HN6口腔鳞癌细胞中CD24表达上调(P<0.05)。相对于癌前病变细胞DOK,口腔鳞癌细胞CAL-27和WSU-HN6具有更强的增殖和肿瘤球成球的潜能(P<0.05)。ATRA能够有效地抑制这两种口腔鳞癌细胞的CD24表达、体外增殖和肿瘤球形成的能力(P<0.05),而CD24抗体虽然也一样能够抑制口腔鳞癌细胞的增殖和肿瘤球形成(P<0.05),但却不影响其CD24的表达。结论:CD24在口腔鳞癌中表达上调,具有促进口腔鳞癌细胞增殖和肿瘤球形成的作用,维甲酸和CD24抗体皆能以CD24为靶点有效地抑制口腔鳞癌细胞的增殖和肿瘤球形成。

关 键 词:,口腔肿瘤,癌,鳞状细胞,抗原,CD24,维甲酸,细胞增殖,

Expression,roles and therapy target values of CD24 in oral squamous cell carcinoma
MO Heng,GAO Cheng-zhi,WANG Shao-jie,LI Mei,DONG Jian-qiang,YU Wei-dong.Expression,roles and therapy target values of CD24 in oral squamous cell carcinoma[J].Journal of Peking University:Health Sciences,2016,48(1):16-22.
Authors:MO Heng  GAO Cheng-zhi  WANG Shao-jie  LI Mei  DONG Jian-qiang  YU Wei-dong
Institution:(1.Department of Stomatology, 2. Department of Chinese Medicine, 3. Institute of Clinical Molecular Biology, Peking University People’s Hospital, Beijing 100044, China)
Abstract:Objective:To determine the expression profile and potential roles of CD24 in oral squamous cell carcinoma and explore the values of CD24 function as a potential target of clinical therapy.Me-thods:Semi-quantitative immunohistochemistry was used to construct the expression profile of CD24 in 78 human oral tissues and 59 Hamster buccal pouch tissues.Real-time RT-PCR and Western blot were used to analyze the CD24 expression levels in oral DOK4 cells,oral cancer CAL-27 and WSU-HN6 cells. Then these two cancer cell lines were selected to evaluate the effect of all-trans retinoic acid (ATRA)and CD24 antibody on CD24 expression,and the proliferation and tumorsphere formation capacity of these two cell lines.Results:CD24 expression was found significantly elevated in both human and animal tissues compared with normal and benign tissues (P<0.05),as well as in oral cancer CAL-27 and WSU-HN6 cells compared with DOK cells (P<0.05).CAL-27 and WSU-HN6 cells possess increased proliferative and specific tumorsphere formation capability compared with DOK cells (P<0.05 ).Both ATRA and CD24 antibody were able to effectively inhibit the proliferation and tumorsphere formation of CAL-27 and WSU-HN6 cells (P<0.05).Among them ATRA at least involved partially in the proliferation by down-regulating the CD24 expression (P<0.05 ),while CD24 antibody blocking had no effect on the CD24 expression.Conclusion:CD24 was upregulated in oral cancer and functioned as a potential factor that promoted the proliferation and tumorsphere formation of CAL-27 and WSU-HN6 cells.Both ATRA and CD24 antibody might effectively inhibit the proliferation and tumorsphere formation of CAL-27 and WSU-HN6 cells and function as a potential therapy target.
Keywords:Mouth neoplasms  Carcinoma  squamous cell  Antigens  CD24  Tretinoin  Cell proliferation
本文献已被 万方数据 等数据库收录!
点击此处可从《北京大学学报(医学版)》浏览原始摘要信息
点击此处可从《北京大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号